EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma

Dokyeong Kim, Junseong Park, Hyeon-Chun Park, Songzi Zhang, Minyoung Park, Soon A Park, Sug Hyung Lee, Youn Soo Lee, Jae-Sung Park, Sin-Soo Jeun, Yeun-Jun Chung, Stephen Ahn

Cancer Cell International · 18.01.2024 · 24 (1)

DOI: 10.1186/s12935-024-03225-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell International, online erschienen am 18.01.2024. Verfasst von Dokyeong Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Seoul St. Mary's Hospital, Catholic University of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although meningioma is the most common primary brain tumor, treatments rely on surgery and radiotherapy, and recurrent meningiomas have no standard therapeutic options due to a lack of clinically relevant research models. Current meningioma cell lines or organoids cannot reflect biological features of patient tumors since they undergo transformation along culture and consist of only tumor cells without microenvironment. We aim to establish patient-derived meningioma organoids (MNOs) preserving diverse cell types representative of the tumor microenvironment.

Methods

The biological features of MNOs were evaluated using WST, LDH, and collagen-based 3D invasion assays. Cellular identities in MNOs were confirmed by immunohistochemistry (IHC). Genetic alteration profiles of MNOs and their corresponding parental tumors were obtained by whole-exome sequencing.

Results

MNOs were established from four patients with meningioma (two grade 1 and two grade 2) at a 100% succession rate. Exclusion of enzymatic dissociation-reaggregation steps endowed MNOs with original histology and tumor microenvironment. In addition, we used a liquid media culture system instead of embedding samples into Matrigel, resulting in an easy-to-handle, cost-efficient, and time-saving system. MNOs maintained their functionality and morphology after long-term culture (> 9 wk) and repeated cryopreserving-recovery cycles. The similarities between MNOs and their corresponding parental tumors were confirmed by both IHC and whole-exome sequencing. As a representative application, we utilized MNOs in drug screening, and mifepristone, an antagonist of progesterone receptor, showed prominent antitumor efficacy with respect to viability, invasiveness, and protein expression.

Conclusion

Taken together, our MNO model overcame limitations of previous meningioma models and showed superior resemblance to parental tumors. Thus, our model could facilitate translational research identifying and selecting drugs for meningioma in the era of precision medicine.

Schlagwörter

Stichwörter der Autor:innen

Brain tumorMeningiomaOrganoidPrecision medicineTumor microenvironment

Autor:innen und Institutionen

  • Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Cancer Evolution Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Microbiology, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
  • Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
  • Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Seoul St. Mary's Hospital, Catholic University of Korea

Zitieren

APA

Kim, D., Park, J., Park, H. C., Zhang, S., Park, M., Park, S. A., Lee, S. H., Lee, Y. S., Park, J. S., Jeun, S. S., Chung, Y. J., & Ahn, S. (2024). Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma. Cancer Cell International, 24(1). https://doi.org/10.1186/s12935-024-03225-4

Vancouver

Kim D, Park J, Park HC, Zhang S, Park M, Park SA, et al. Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma. Cancer Cell International. 2024;24(1). doi:10.1186/s12935-024-03225-4

BibTeX
@article{Kim2024,
  author = {Kim, Dokyeong and Park, Junseong and Park, Hyeon-Chun and Zhang, Songzi and Park, Minyoung and Park, Soon A and Lee, Sug Hyung and Lee, Youn Soo and Park, Jae-Sung and Jeun, Sin-Soo and Chung, Yeun-Jun and Ahn, Stephen},
  title = {Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma},
  journal = {Cancer Cell International},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12935-024-03225-4}
}
Kostenlos starten →